Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 11 - Drugs for disorders of the respiratory system
Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767)
09/2003
09/24/2003EP1346225A2 Method for identifying substances which positively influence inflammatory conditions of chronic inflammatory airway diseases
09/24/2003EP1346056A1 Methods for the production of multimeric proteins, and related compositions
09/24/2003EP1346055A2 Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof
09/24/2003EP1346053A2 Polynucleotides encoding human phosphatases
09/24/2003EP1346043A2 Compositions and methods relating to lung specific genes and proteins
09/24/2003EP1345968A2 Crystals of whole antibodies and fragments thereof and methods for making and using them
09/24/2003EP1345956A2 Intracellular delivery of biological effectors by novel transporter peptide sequences
09/24/2003EP1345946A1 Macroheterocylic compounds useful as kinase inhibitors
09/24/2003EP1345938A1 Tricyclic crf receptor antagonists
09/24/2003EP1345937A1 Quinuclidine carbamate derivatives and their use as m3 antagonists
09/24/2003EP1345936A1 Method for producing the anticholinergic agent tiotropium bromide
09/24/2003EP1345933A2 Process for making substituted 8-arylquinolinium benzenesulfonate
09/24/2003EP1345929A2 Pyrazole compounds useful as protein kinase inhibitors
09/24/2003EP1345928A2 Pyrazole compounds useful as protein kinase inhibitors
09/24/2003EP1345927A1 Pyrazole compounds useful as protein kinase inhibitors
09/24/2003EP1345926A2 Pyrazole compounds useful as protein kinase inhibitors
09/24/2003EP1345925A2 Pyrazole compounds useful as protein kinase inhibitors
09/24/2003EP1345922A1 Pyrazole compounds useful as protein kinase inhibitors
09/24/2003EP1345920A1 Novel sulfamides and their use as endothelin receptor antagonists
09/24/2003EP1345910A1 Quinazoline derivatives, medicaments containing said compounds, their utilization and method for the production thereof
09/24/2003EP1345902A1 Substituted heterocyclo-norbornylamine derivatives, method for producing the same, their use as medicament or diagnostic agent and medicament containing the same
09/24/2003EP1345899A1 Compounds
09/24/2003EP1345898A2 Teracyclic carbazole derivates and their use as spla2 inhibitors
09/24/2003EP1345626A2 Novel pharmaceutical compositions based on anticholinergic agents and dopamine agonists
09/24/2003EP1345625A2 Methods of administering/dosing anti-rsv antibodies for prophylaxis and treatment
09/24/2003EP1345607A1 Therapeutic combination of amlodipine and benazepril / benazeprilat
09/24/2003EP1345603A1 (halo-benzo carbonyl)heterocyclo fused phenyl p38 kinase inhibiting agents
09/24/2003EP1345591A1 Pharmaceutical aerosol formulation
09/24/2003EP1272489B1 Process for preparing crystalline form i of cabergoline
09/24/2003EP1259512B1 Pteridine compounds for the treatment of psoriasis
09/24/2003EP1252163B1 4-pyridyl-and 2,4-pyrimidinyl-substituted pyrrole derivatives and their use in pharmacy
09/24/2003EP1242396B1 New p2x 7 receptor antagonists for use in the treatment of inflammatory, immune or cardiovascular diseases
09/24/2003EP1196419B1 Potassium channel blocking agents
09/24/2003EP1181190B1 Method and apparatus for loading a container with a product
09/24/2003EP1165558B1 Derivatives of pyrimido[6,1-a]isoquinolin-4-one
09/24/2003EP1150953B1 Indole derivatives and their use as mcp-1 receptor antagonists
09/24/2003EP0944618B1 Novel n-benzenesulphonyl-l-proline derivatives, method for preparing and therapeutic use
09/24/2003EP0938345B1 Aqueous-based pharmaceutical composition
09/24/2003EP0938322B1 Use of uridine triphosphate related compounds for the prevention and treatment of pneumonia in immobilized patients
09/24/2003EP0736022B1 5-(2-imidazolinylamino)benzimidazole derivatives, their preparation and their use as alpha-2 adrenoceptor agonists
09/24/2003CN1444654A Novel therapeutic molecular variants and uses thereof
09/24/2003CN1444597A 2-substituted pregna-1,3,5(10)-triene and chola-1,3,5(10)-triene derivatives and their biological activity
09/24/2003CN1444589A 4-phenyl-pyridine derivatives as neurokinin-1 receptor antagonists
09/24/2003CN1444587A Dihydropyridine soft drug and related to composition and method
09/24/2003CN1444581A 3-indolyl-4-phenyl-1H-pyrrole-2, 5-dione derivatives as inhibitors of glycogen synthase kinase-3beta
09/24/2003CN1444579A 2,2-disubstituted 1,3,-dioxolanes as antitussive agents
09/24/2003CN1444578A 1,3-dioxolanes with antitussive activity
09/24/2003CN1444573A Carboxamide compounds and their use as antagonists of human 11CBY receptor
09/24/2003CN1444572A 2-aminothiazoline derivatives and their use as no-synthase inhibitors
09/24/2003CN1444570A Non-steroidal inflammation inhibitors
09/24/2003CN1444489A Aerosol container for formulations of salmeterol xinafoate
09/24/2003CN1444484A Immunotherapy treating bacterial or viral infection at mucosal surface with probiotics, and composition therefor
09/24/2003CN1444476A Method for reducing exacerbations associated with COPD
09/24/2003CN1443562A Medicinal and edible product for supportive prevention and therapy of atypical pneumonia and safely reducing weight and its preparation method
09/24/2003CN1443555A Medicine plaster for curing laryngopharyngitis and its preparation method
09/24/2003CN1443531A Oral cavity adhesive plaster composition for curing gingival disease, laryngopharyngitis and halitosis
09/24/2003CN1122037C Thiophene [2,3,-d] hybar X compound and its preparing method, use and medical composition containing it
09/24/2003CN1122022C Substituted oximes as neurokinin antagonists
09/23/2003US6624295 Heavy chain and light chain peptides comprising complement determining regions, including single chain FV fragments, used as thrombolytic agents
09/23/2003US6624202 Inhibitors of copper-containing amine oxidases
09/23/2003US6624199 Prophylaxis and treatment of acne and acne related skin diseases with aminobenzophenones, and novel compounds effective in the treatment, as well as pharmaceutical preparations containing these compounds and dosage units
09/23/2003US6624186 Modulators of SKCa, IKCa and BKCa channels.
09/23/2003US6624180 Substituted polycyclic aryl and heteroaryl pyridines useful for selective inhibition of the coagulation cascade
09/23/2003US6624176 Heteroaromatic substituted amides with antagonistic activity to neurokinin 1 receptors
09/23/2003US6624167 Compounds that are capable of affecting nicotinic cholinergic receptors. A wide variety of conditions and disorders, and particularly conditions and disorders associated with dysfunction of the central and autonomic nervous systems can
09/23/2003US6624164 1,3-dihydro-2H-indol-2-one derivatives, preparation method and pharmaceutical composition containing them
09/23/2003US6624163 P-acylaminomethyl-N-(4-methoxy-7-morpholin-4-yl-benzothiazol-2 -yl)-benzamides; treatment of diseases related to the adenosine receptor, such as Alzheimer's disease, depression, drug addiction, Parkinson's and Attention Deficit Hyperactivity Disorder
09/23/2003US6624158 Purine derivatives
09/23/2003US6624152 Inhibition and prevention of cell adhesion and cell adhesion-mediated pathologies. This invention relates to pharmaceutical formulations comprising these compounds and methods of using them for inflammatory and autoimmune diseases
09/23/2003US6623767 Mixture containing honey, at least one essential oil and/or at least one essential oil derivative
09/23/2003US6623754 Comprises granulated rheology modifying polymers (modified acrylic acid-methacrylic acid homopolymers/copolymers) for making tablets by direct compression, without granulation first; bioavailability
09/23/2003US6623723 Method for treating bronchial constriction and bronchospasm
09/23/2003CA2285005C Sequential release throat drops for relief of cough and cold
09/23/2003CA2275527C Novel heterocyclic substituted pyrrolidine amide derivatives
09/23/2003CA2268927C Aqueous-based pharmaceutical composition
09/18/2003WO2003076565A2 Methods of using 46828, a human acyl-coa synthetase
09/18/2003WO2003076458A2 Selective dipeptide inhibitors of kallikrein
09/18/2003WO2003076447A1 An optically acitve pyridine derivative and a medicament containing the same
09/18/2003WO2003076443A1 Spiro compounds with npy antagonistic activity
09/18/2003WO2003076438A1 Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase
09/18/2003WO2003076436A1 Derivatives of 4- (imidazol-5-yl)-2-(4-sulfoanilino) pyrimidine with cdk inhibitory activity
09/18/2003WO2003076432A1 Benzodiazepine-substituted piperidines for utilization in the treatment of cardiovascular diseases
09/18/2003WO2003076430A1 Amino-derivatives as novel inhibitors of histone deacetylase
09/18/2003WO2003076424A1 Macrocyclic compounds useful as pharmaceuticals
09/18/2003WO2003076421A1 Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase
09/18/2003WO2003076417A2 Oxo-azabicyclic compounds
09/18/2003WO2003076416A1 Oxo azabicyclic compounds
09/18/2003WO2003076407A1 Novel chalcone derivatives and uses thereof
09/18/2003WO2003076406A1 Nitrosodiphenylamine derivatives and their pharmaceutical use against oxidative stress pathologies
09/18/2003WO2003076405A1 Monocyclic aroylpyridinones as antiinflammatory agents
09/18/2003WO2003076401A1 Sulfonylamino-derivatives as novel inhibitors of histone deacetylase
09/18/2003WO2003076400A1 New inhibitors of histone deacetylase
09/18/2003WO2003076399A1 Compounds capable of inhibiting immunocyte-related allergic immune reactions
09/18/2003WO2003075932A1 1-alpha-hydroxy-2-methylene-19-nor-pregnacalciferol and its uses
09/18/2003WO2003075929A1 Inhibitors of histone deacetylase
09/18/2003WO2003075926A1 Use of proton pump inhibitors for the treatment of airway disorders
09/18/2003WO2003075921A2 Mono- and bicyclic azole derivatives that inhibit the interaction of ligands with rage
09/18/2003WO2003075900A2 Utilization of ubiquinones for influencing the effect of histamine
09/18/2003WO2003075857A2 Amino-methyl substituted tetracycline compounds
09/18/2003WO2003075847A2 NOVEL CURCUMINOID-FACTOR VIIa CONSTRUCTS AS SUPPRESSORS OF TUMOR GROWTH AND ANGIOGENESIS
1 ... 577 578 579 580 581 582 583 584 585 586 587 588 589 590 591 592 593 594 595 596 597 ... 878